pocH-100i

"This CLIA-waived hematology analyzer produces acceptable results and can be used in offices and clinics."

"The ABO antibody titers were significantly reduced after addition of PAS. This facilitates the ABO incompatible SDP transfusion and helps in inventory management. The risk of allergic transfusion reaction decreases after reducing the amount of plasma from SDP units. Using PAS-SDP certainly improve the inventory management for platelets with no compromise on clinical and laboratory efficacy."

"The establishment of a stand-alone unit and laboratory dedicated to the care of patients with EVD minimizes the risk of spreading EVD among hospital patients and employees. Risk assessment, instrument validation, and employee training are major components that contribute to the success of establishing this type of laboratory."

"In conclusion, DNA methylation in a BDNF and one OXTR target sequence was greater in peripheral blood of adults reporting low compared to those reporting high maternal care during childhood and adolescence. These results could improve the understanding of how maternal care influences the epiphenotype in humans."

The Sysmex pocH-100i haematology analyser provides a reliable, low-cost alternative to flow cytometry for CD4+ T-cell monitoring in resource-limited settings. By using a simplified immunomagnetic isolation technique, the system achieves a 93% concordance with gold-standard methods while requiring minimal technical expertise. This point-of-care solution is particularly valuable because it simultaneously delivers a complete blood count (CBC) to monitor ART side effects, allowing for immediate clinical decisions and improved HIV staging for both adults and children during a single patient visit.

"A digital imaging instrument with an inexpensive hematology analyzer provides similar information to a complex hematology analyzer and allows remote review of the blood smear findings by experts, leading to significant cost savings."

"The HemoScreen device demonstrated the best clinical concordance in ANC values at medical decision thresholds for clozapine therapy management."

In summary, the evaluation of the Sysmex pocH-100i demonstrates that this compact analyser is a highly reliable tool for near-patient testing within an outdoor oncology setting. The device exhibits strong technical performance, with imprecision levels generally remaining below 5% and maintaining dependable accuracy even for low-range platelet counts. While a notable portion of samples may require professional review due to flagging or "vote-outs," the system’s high comparability with large-scale laboratory analysers confirms its clinical utility. When integrated into a structured management plan, the pocH-100i provides a robust and efficient solution for immediate haematological assessment in oncology patients.

The performance evaluation conducted at St. John's Regional Health Center demonstrates that the Sysmex pocH-100i is a highly reliable and efficient automated hematology analyzer. By comparing it against the established Sysmex KX-21N, the study confirmed that the pocH-100i delivers excellent correlation across 17 key parameters, including comprehensive leukocyte differentials and red blood cell indices. Its compact design and minimal sample volume requirements do not compromise its analytical precision; in fact, the integration of hydrodynamic focusing significantly enhances the accuracy of red blood cell and platelet measurements. With carryover, reproducibility, and linearity results all falling well within manufacturer specifications, the pocH-100i proves to be a robust clinical tool. Ultimately, the analyzer's overall performance is excellent, making it a favorable and effective solution for the North American marketplace.

The Sysmex pocH-100i is a highly reliable compact analyzer that delivers laboratory-grade precision in a point-of-care format. By providing accurate full blood counts and 3-part differentials - specifically separate neutrophil reporting - it proves equivalent to larger systems like the KX-21N. This makes it an ideal, high-performance solution for low-volume laboratories and oncology monitoring where space and efficiency are critical.